QDEL
NASDAQ
Health Care
$17.38
USD
-$0.86 (-4.71%)
At close: Jul 17, 2026, 4:00 PM EDT
Market Cap:
$1.24B
Volume:
1.1M
Previous Close
$18.24
Day Range
$17.26 - $18.19
52 Week Range
$9.92 - $35.58
Average Volume (10 Days)
1.2M
P/E Ratio (TTM)
—
Dividend Yield
—
QuidelOrtho Corp. operates as a vitro diagnostics company. The company is headquartered in San Diego, California and currently employs 6,500 full-time employees. The firm specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. The company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.
CEO
Mr. Douglas Bryant
Headquaters
San Diego, CALIFORNIA, US
Founded
1991
Employees
6,500
LNTH
Lantheus Holdings Inc
$107.59
+2.4%
ICUI
ICU Medical Inc
$157.51
-2.9%
NEOG
Neogen Corp
$10.27
-0.6%
STAA
STAAR Surgical Co
$26.44
-8.8%